NR

Nayanaben Rajubhai Thanth

Active Director Designated Partner DIN 11657934
DIN 11657934 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nayanaben Rajubhai Thanth

Data last updated:

Nayanaben Rajubhai Thanth is a Designated Partner at Prayosha Lifesciences Llp (since 2026).

DIN 11657934
Primary Designation Designated Partner
First Appointment 10 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 Apr 20262026Active

Board colleagues of Nayanaben Rajubhai Thanth

NameDINCompanyDesignation
Paresh Kalubhai Bharodiya11657933Prayosha Lifesciences LlpDesignated Partner
Sonalkumari Sunilbhai Patel11657932Prayosha Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Prayosha Lifesciences Llp
Premium access

Shareholding and investment profile for Nayanaben Rajubhai Thanth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nayanaben Rajubhai Thanth

Nayanaben Rajubhai Thanth currently holds 1 directorship: Prayosha Lifesciences Llp (Designated Partner, since 10 Apr 2026).

Nayanaben Rajubhai Thanth was first appointed on 10 Apr 2026 as Designated Partner at Prayosha Lifesciences Llp.

The current boards of Nayanaben Rajubhai Thanth's companies include Paresh Kalubhai Bharodiya (Prayosha Lifesciences Llp), Sonalkumari Sunilbhai Patel (Prayosha Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available